title: Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds.
abstract: Naturally occurring five-membered heterocyclic aldehydes, including 5-hydroxymethyl-2-furfural, increase the oxygen affinity of hemoglobin (Hb) and strongly inhibit the sickling of homozygous sickle red blood (SS) cells. X-ray studies of Hb complexed with these compounds indicate that they form Schiff base adducts in a symmetrical fashion with the N-terminal alphaVal1 nitrogens of Hb. Interestingly, two cocrystal types were isolated during crystallization experiments with deoxygenated Hb (deoxyHb): one crystal type was composed of the low-affinity or tense (T) state Hb quaternary structure; the other crystal type was composed of high-affinity or relaxed state Hb (with a R2 quaternary structure). The R2 crystal appears to be formed as a result of the aldehydes binding to fully or partially ligated Hb in the deoxyHb solution. Repeated attempts to crystallize the compounds with liganded Hb failed, except on rare occasions when very few R state crystals were obtained. Oxygen equilibrium, high performance liquid chromatography (HPLC), antisickling, and X-ray studies suggest that the examined heterocyclic aldehydes may be acting to prevent polymerization of sickle hemoglobin (HbS) by binding to and stabilizing liganded Hb in the form of R2 and/or various relaxed state Hbs, as well as binding to and destabilizing unliganded T state Hb. The proposed mechanism may provide a general model for the antisickling effects of aldehyde containing small molecules that bind to N-terminal alphaVal1 nitrogens of Hb. The examined compounds also represent a new class of potentially therapeutic agents for treating sickle cell disease (SCD).
authors.affiliation: Department of Medicinal Chemistry, School of Pharmacy and Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond, Virginia 23298, USA. msafo@mail2.vcu.edu
authors.forename: Martin K
authors.initials: MK
authors.lastname: Safo
authors.forename: Osheiza
authors.initials: O
authors.lastname: Abdulmalik
authors.forename: Richmond
authors.initials: R
authors.lastname: Danso-Danquah
authors.forename: James C
authors.initials: JC
authors.lastname: Burnett
authors.forename: Samuel
authors.initials: S
authors.lastname: Nokuri
authors.forename: Gajanan S
authors.initials: GS
authors.lastname: Joshi
authors.forename: Faik N
authors.initials: FN
authors.lastname: Musayev
authors.forename: Toshio
authors.initials: T
authors.lastname: Asakura
authors.forename: Donald J
authors.initials: DJ
authors.lastname: Abraham
mesh_terms: D000447:Aldehydes / Q000737:chemistry* / Q000145:classification / Q000494:pharmacology*; D000755:Anemia, Sickle Cell / Q000097:blood / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism; D000986:Antisickling Agents / Q000737:chemistry* / Q000145:classification / Q000494:pharmacology*; D001665:Binding Sites; D002851:Chromatography, High Pressure Liquid; D018360:Crystallography, X-Ray; D003500:Cyclization; D005663:Furans / Q000737:chemistry; D006451:Hemoglobin, Sickle / Q000737:chemistry / Q000378:metabolism; D006720:Homozygote; D006801:Humans; D008958:Models, Molecular; D015394:Molecular Structure; D010100:Oxygen / Q000737:chemistry; D017434:Protein Structure, Tertiary; D013329:Structure-Activity Relationship
chemical_list: D000447:Aldehydes; D000986:Antisickling Agents; D005663:Furans; D006451:Hemoglobin, Sickle; D010100:Oxygen; C039281:furan